BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37567436)

  • 21. DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis.
    Barton CE; Tahinci E; Barbieri CE; Johnson KN; Hanson AJ; Jernigan KK; Chen TW; Lee E; Pietenpol JA
    Dev Biol; 2009 May; 329(1):130-9. PubMed ID: 19272371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma.
    Pokorna Z; Vyslouzil J; Vojtesek B; Coates PJ
    Cell Mol Biol Lett; 2022 Feb; 27(1):18. PubMed ID: 35196980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
    Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
    PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth.
    Mattiske S; Ho K; Noll JE; Neilsen PM; Callen DF; Suetani RJ
    Oncotarget; 2013 Nov; 4(11):1894-903. PubMed ID: 24177167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
    Yan W; Chen X; Zhang Y; Zhang J; Jung YS; Chen X
    J Biol Chem; 2013 Feb; 288(5):2907-13. PubMed ID: 23271742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion.
    Wu J; Liang S; Bergholz J; He H; Walsh EM; Zhang Y; Xiao ZX
    Cell Death Dis; 2014 Jun; 5(6):e1280. PubMed ID: 24901051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
    Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
    J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.
    Tucci P; Agostini M; Grespi F; Markert EK; Terrinoni A; Vousden KH; Muller PA; Dötsch V; Kehrloesser S; Sayan BS; Giaccone G; Lowe SW; Takahashi N; Vandenabeele P; Knight RA; Levine AJ; Melino G
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15312-7. PubMed ID: 22949650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activin A Increases Human Trophoblast Invasion by Inducing SNAIL-Mediated MMP2 Up-Regulation Through ALK4.
    Li Y; Klausen C; Zhu H; Leung PC
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1415-27. PubMed ID: 26305619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The miR-124-p63 feedback loop modulates colorectal cancer growth.
    Liu K; Yao H; Lei S; Xiong L; Qi H; Qian K; Liu J; Wang P; Zhao H
    Oncotarget; 2017 Apr; 8(17):29101-29115. PubMed ID: 28418858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Wu TS; Tan CT; Chang CC; Lin BR; Lai WT; Chen ST; Kuo MY; Rau CL; Jaw FS; Chang HH
    Oncogene; 2015 Mar; 34(10):1207-19. PubMed ID: 24681956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
    Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
    Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
    Dil N; Banerjee AG
    Head Neck Oncol; 2011 Sep; 3():44. PubMed ID: 21958730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma.
    Hu L; Liu J; Li Z; Wang C; Nawshad A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):460-482.e4. PubMed ID: 27567435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer.
    Zhao J; Fang Z; Zha Z; Sun Q; Wang H; Sun M; Qiao B
    Eur J Pharmacol; 2019 Mar; 847():11-18. PubMed ID: 30639311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
    Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The foggy world(s) of p63 isoform regulation in normal cells and cancer.
    Pokorná Z; Vysloužil J; Hrabal V; Vojtěšek B; Coates PJ
    J Pathol; 2021 Jul; 254(4):454-473. PubMed ID: 33638205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.